Arrowhead Pharmaceuticals, Inc.
Alpha-v beta-6 integrin ligands and uses thereof

Last updated:

Abstract:

Integrin ligands having serum stability and affinity for .alpha.v.beta.6 integrins are described. Compositions comprising .alpha.v.beta.6 integrin ligands having serum stability and having affinity for .alpha.v.beta.6 integrins and methods of using them are also described.

Status:
Grant
Type:

Utility

Filling date:

30 Apr 2019

Issue date:

23 Nov 2021